Paritaprevir/ritonavir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Paritaprevir/ritonavir, covering 2018-11-14 to 2018-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation